CINCA syndrome, also known as Chronic Infantile Neurological Cutaneous and Articular syndrome, is an extremely rare autoinflammatory disorder. Due to its rarity, the prevalence of CINCA syndrome is quite low. Exact figures regarding its prevalence are challenging to determine, but it is estimated to affect approximately 1 in every 1,000,000 individuals worldwide.
CINCA syndrome is characterized by a range of symptoms including chronic inflammation of the skin, joints, and nervous system. It typically manifests in early infancy and persists throughout a person's life. The condition can lead to various complications such as growth delays, hearing loss, vision problems, and neurological impairments.
Although CINCA syndrome is a rare disorder, its impact on affected individuals and their families can be significant. Early diagnosis and appropriate management are crucial in improving the quality of life for those living with this condition. Ongoing research and advancements in medical understanding are essential for better understanding the prevalence and treatment options for CINCA syndrome.